|
C/NL/06/01_001
|
Suntory Flowers Limited
|
Application for renewal of consent for marketing approval under Directive 2001/18/EC (Event FLORIGENE®Moonaqua™(FLO-4Ø689-6))
|
09-11-2018
|
Vergunning verleend
|
|
IM-MV 18-004_000
|
Universitair Medisch Centrum Utrecht
|
Phase I/II multicenter clinical trial of VXM01 in combination with avelumab in patients with progressive glioblastoma and further clinical studies with VXM01 in patients with solid malignancies.
|
|
Ontwerpbesluit genomen
|
|
IM-MV 18-009_000
|
Universitair Medisch Centrum Utrecht
|
Clinical testing of KITE-585, an autologous cellular immunotherapy composed of T cells genetically modified ex vivo to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumor cells
|
18-12-2018
|
Vergunning verleend
|
|
IM-MV 18-016_000
|
Erasmus MC
|
Testing CTL019 in patients with B cell malignancies
|
|
Ontwerpbesluit genomen
|
|
IM-MV 18-017_000
|
Universitair Medisch Centrum Utrecht
|
A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Severe Hemophilia A
|
|
Ontwerpbesluit genomen
|
|
IM-MV 18-018_000
|
AMC
|
A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Hemophilia A
|
|
Ontwerpbesluit genomen
|
|
IM-MV 18-019_000
|
Universitair Medisch Centrum Utrecht
|
Testing CTL019 in patients with B cell malignancies
|
|
Ontwerpbesluit genomen
|
|
IM-MV 18-020_000
|
UMCG
|
A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Severe Hemophilia A
|
|
Ontwerpbesluit genomen
|
